Astrotech (NASDAQ:ASTC) Rating Increased to Sell at Wall Street Zen

Posted by Teresa Graham on Aug 2nd, 2026

Wall Street Zen upgraded shares of Astrotech (NASDAQ:ASTC – Free Report) from a strong sell rating to a sell rating in a research note issued to investors on Saturday morning.

Separately, Weiss Ratings raised shares of Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Astrotech currently has an average rating of “Sell”.

View Our Latest Analysis on Astrotech

Astrotech Stock Up 4.3%

ASTC stock opened at $6.54 on Friday. The firm has a 50 day moving average of $15.14 and a two-hundred day moving average of $7.28. Astrotech has a 12 month low of $1.91 and a 12 month high of $68.85. The company has a market capitalization of $11.77 million, a price-to-earnings ratio of -0.78 and a beta of 4.77.

Astrotech (NASDAQ:ASTC – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) earnings per share for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%. The business had revenue of $0.34 million for the quarter.

Hedge Funds Weigh In On Astrotech

A number of institutional investors have recently modified their holdings of ASTC. Susquehanna International Group LLP acquired a new stake in shares of Astrotech in the third quarter worth $66,000. DRW Securities LLC grew its stake in Astrotech by 168.5% in the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after buying an additional 19,747 shares during the last quarter. Finally, J. Safra Sarasin Holding AG acquired a new position in Astrotech in the 1st quarter valued at $140,000. Institutional investors own 24.35% of the company’s stock.

About Astrotech

(Get Free Report)

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.